Objectives: To evaluate the effectiveness of 0.2% delmopinol mouth rinse in maintenance of peri-implant tissue health and prevention or inhibition of peri-implant mucositis and periimplantitis.
| INTRODUCTION
The number of patients and implants affected by peri-implant disease is increasing over the past decades. Professional maintenance and plaque control at home after implant placement are important preventative measures of peri-implant mucositis and peri-implantitis as a next phase. 1 Peri-implant health is characterized by the absence of erythema, bleeding on probing, swelling, and suppuration. 2 The main clinical characteristic of peri-implant mucositis is bleeding on gentle probing.
Erythema, swelling, and/or suppuration may also be present. An increase in probing depth is often observed in the presence of periimplant mucositis due to swelling or decrease in probing resistance.
Peri-implantitis is a plaque-associated pathological condition, characterized by inflammation in the peri-implant mucosa and subsequent progressive loss of supporting bone. There is strong evidence from animal and human experimental studies that plaque is the etiological factor for peri-implant diseases. 2 Peri-implant health and disease are complex multifactorial conditions that are heavily influenced by the patients' ability to control the bacterial environment around the dental implant. 3, 4 Plaque control has been determined to be a major modifiable factor in the prevention, initiation, and progression of peri-implant disease. 5 Delmopinol molecule, which is an active ingredient of some commercially available anti-plaque/anti-gingivitis dental rinses, binds to plaque causing bacteria. This might help break down plaque and prevents bacteria from attaching and growing on teeth, gums, and implants. 6 Hase and colleagues in 1998 conducted a double-blind, randomized, 6-month clinical trial with parallel group design in 68 subjects with gingivitis to study the effects on the oral flora of delmopinol hydrochloride 2 mg/mL (0.2% wt/vol), when used for partly supervised mouthrinsing in comparison with placebo and chlorhexidine digluconate 2 mg/mL (0.2% wt/vol). They have concluded that delmopinol was accompanied by a composition of the plaque and salivary flora associated with healthy conditions in the oral cavity. 7 In a metaanalyses of studies of 0.2% delmopinol mouth rinse as an adjunct to gingival health and plaque control measures, Addy and colleagues reported that delmopinol 0.2% was superior to placebo for the reduction of plaque scores. The pooled analysis of all eight studies that were included in their review confirmed statistically significant effects of delmopinol 0.2% compared with placebo (P < .00001). They also suggest that delmopinol met the efficacy criteria of the American
Dental Association in studies of extended duration. 8 A previous in vitro study suggested that exposing multispecies biofilms to 2% chlorhexidine or 0.2% delmopinol for 20 minutes significantly reduced the numbers of viable bacteria on the titanium surface. 9 Although delmopinol could be a potential agent for effective plaque control of dental implants as well as natural teeth there is no evidence to show the effectiveness in an in vivo situation.
The purpose of this study is to evaluate the effectiveness of 0.2% delmopinol mouth rinse in maintenance of peri-implant tissue health and prevention or inhibition of peri-implant mucositis and periimplantitis using an established canine peri-implant disease model. 10 
| MATERIALS AND METHODS
A randomized controlled study was conducted in order to evaluate the effectiveness of 0.2% delmopinol mouth rinse in maintenance of peri-implant tissue health and prevention or inhibition of peri-implant mucositis and peri-implantitis.
Overall, six male Mongrel dogs, 18-24 months of age with a body weight range of 15-25 kg, were used in this study at the University of Agronomic Sciences and Veterinary Medicine of Bucharest. Ethic approval was obtained from the University of Agronomic Sciences and Veterinary Medicine prior to the initiation of the study. The study flow chart is depicted in Figure 1 .
Initially, all mandibular premolars were bilaterally extracted using a minimally invasive approach. Four weeks after tooth extraction (T1), four titanium dental implants (TOUAREG CloseFit Implant System, ADIN Dental implant System Ltd) with the diameter of 3.5 mm were be placed on each hemi-arch of the mandible. All implants were immediately connected to commercially available healing abutments (ADIN Dental implant System Ltd).
The six dogs were then assigned to either of two groups and received the assigned product application for 16 weeks after T1 twice a day at least 6 hours apart. Eating and drinking was avoided for 30 minutes after the application of assigned product. The test agent was a mouth rinse that contains 0.2% delmopinol HCL as active ingredient (provided by Sunstar Americas, Inc, Schaumberg, Illinois).
The control agent was prepared with the same ingredients excluding the active ingredient. The test and placebo agents were made in the laboratory based on a commercial product formulation.
Eight weeks following implant installation (T2), ligatures were placed around the dental implants as previously described. 10 Before placing the ligatures, the surfaces of all implants/abutment were mechanically cleaned. Mechanical cleaning of both natural teeth and implants was not performed after ligature placement.
Wound Healing Index was recorded at T2 based on an assessment of the peri-implant mucosal tissue superficially: score 1, uneventful wound healing with no mucosal edema, erythema, discomfort, or suppuration; score 2, uneventful wound healing with slight mucosal edema, erythema, or discomfort, but no suppuration; score 3, poor wound healing with mucosal edema, erythema, discomfort, and/or suppuration. 
| RESULTS
Overall, healing was uneventful following the extractions and implant placement and all implants demonstrated osseointegration following implant placement. Plaque accumulation at implant sites before ligature placement (T2) was lower for the test group (test, 0.7 AE 1.0; placebo, 1.5 AE 1.3, P < .05; Figure 2 ). PD at T2 in the placebo group was greater than that of the test group (test, 3.2 AE 0.7 mm; placebo, 4.2 AE 1.2 mm, P < .01; Figure 3 ). The ratio of affected implants (PD ≧4 mm) at T2 and T4 in the test group was significantly smaller than that of the placebo group (T2, 17% vs 47%, P < .01; T4, 67% vs 83%, P < .05; Table 1 ).
Bleeding on probing and gingival index were increased following ligature placement as expected in both groups; however, there was no significant difference between the test group and the placebo group (BOP; T2, 0% vs 0%; T4, 20% vs 21%). The wound healing index was significantly better in the test group as compared to the control group at T2 (Figure 4 ). 14 A cause-and-effect relationship between experimental accumulation of bacterial biofilms around titanium dental implants and the development of an inflammatory response was documented in humans. [14] [15] [16] Biofilm control should be considered the standard of care for management of peri-implant mucositis administered either by the patient or the oral healthcare professional. 1, 14, 17 Delmopinol is a low molecular weight substituted aminoalcohol which has been shown to be effective clinically in the inhibition of plaque and gingivitis at concentration of 0.2%. [18] [19] [20] [21] Its efficacy is thought to be based on the ability to interfere with the bacterial matrix formation, inhibit the adhesion of bacteria and cause a looser biofilm that is easier to remove. 8, 22 Delmopinol was developed as an agent with comparably modest antimicrobial properties and promotes a microbial flora compatible with dental health. 18, 23, 24 It is a highly surface-active compound and reduces the surface tension of saliva and increases the wettability of tooth surfaces. 18 The compound binds to hard and soft oral tissues as well as to bacterial surfaces and affects several of the steps in the formation and establishment of dental biofilms. 24 These include displacement of components from the pellicle and interference with the buildup and cohesion of plaque by reducing glucan synthesis and glucan viscosity. 22, 24 Delmopinol may also reduce cell-to-cell adhesion by changing the colloidal stability of bacterial suspensions and by detaching or solubilizing surface structures of oral bacteria. cebo. 25 While chlorhexidine showed greater plaque reduction than delmopinol at 6 months, no statistically significant difference was reached between these two solutions regarding BOP. 25 In a study by Ready and colleagues, 9 titanium disks were used to provide a simple and smooth commercially-pure titanium surface on which a multispecies biofilm could be cultured and subsequently accumulation and clinical parameters of inflammation was similar to the placebo group after ligature placement, it might be stipulated that due to the reduced initial plaque accumulation, the test group showed better results in bone-implant contact indices and bone loss surrounding dental implants comparing to the placebo group. It can be assumed that the effect of delmopinol on peri-implant inflammation via prohibiting plaque accumulation during the healing period might retard the progression of peri-implantitis induced by placement of ligatures.
Following implant placement, a strict follow-up regime with a dental professional should be implemented to monitor the implant and surrounding teeth for disease. The dental professional should continually encourage the patient to adhere to consistent homecare to prevent peri-implantitis from occurring and in turn increase the success of their implants. 1 The results of the study indicate that the 0.2% delmopinol mouth rinse might play a role in prevention of peri-implant disease development through the plaque control mechanism. As this is a canine study, the ability to generalize the results and apply it to the clinical practice is limited. Moreover, the ligature model only mimics the real-life condition of peri-implant disease and is only a simplified representation of the disease. However, within the limitation of this canine model, the results of the present study might indicate that the use of 0.2% delmopinol mouth rinse in addition to the oral hygiene mechanical cleaning could benefit soft and hard tissue stability and health around dental implants. Although the cohort is small, the effect that was shown on the bone loss is rather interesting and could be attributed to the anti-plaque effect of the delmopinol. Further studies in patients with dental implants are warranted to better understand the efficacy of delmopinol in prevention of peri-implant disease.
